UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene

Antimicrobial Agents and Chemotherapy, 2010-08, Vol.54 (8), p.3505-3508

2010

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6284-6289

2013

Link zum Volltext

Verfügbarkeit prüfen

Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance

Antimicrobial Agents and Chemotherapy, 2007-02, Vol.51 (2), p.510-520

2007

Link zum Volltext

Verfügbarkeit prüfen

Posaconazole Pharmacodynamic Target Determination against Wild-Type and Cyp51 Mutant Isolates of Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

Antimicrobial Agents and Chemotherapy, 2013-01, Vol.57 (1), p.579-585

2013

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of an In Vivo Candida albicans Biofilm Denture Model

Infection and Immunity, 2010-09, Vol.78 (9), p.3650-3659

2010

Link zum Volltext

Verfügbarkeit prüfen

An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

Nature communications, 2020-12, Vol.11 (1), p.6429-17, Article 6429

2020

Link zum Volltext

Verfügbarkeit prüfen

Host contributions to construction of three device-associated Candida albicans biofilms

Infection and immunity, 2015-12, Vol.83 (12), p.4630-4638

2015

Link zum Volltext

Verfügbarkeit prüfen

Isavuconazole Pharmacodynamic Target Determination for Candida Species in an In Vivo Murine Disseminated Candidiasis Model

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5642-5648

2013

Link zum Volltext

Verfügbarkeit prüfen

Impact of In Vivo Triazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy against Cyp51 Mutant Isolates

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5438-5447

2013

Link zum Volltext

Verfügbarkeit prüfen

Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model

Antimicrobial Agents and Chemotherapy, 2012-11, Vol.56 (11), p.5916-5922

2012

Link zum Volltext

Verfügbarkeit prüfen

Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo

Eukaryotic Cell, 2007-06, Vol.6 (6), p.931-939

2007

Link zum Volltext

Verfügbarkeit prüfen

Engineering of Streptomyces platensis MA7339 for Overproduction of Platencin and Congeners

Organic letters, 2010-04, Vol.12 (8), p.1744-1747

2010

Link zum Volltext

Verfügbarkeit prüfen

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Antimicrobial Agents and Chemotherapy, 2011-04, Vol.55 (4), p.1543-1548

2011

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.1265-1272

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

Antimicrobial agents and chemotherapy, 2017-05, Vol.61 (5)

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2019-07, Vol.63 (7)

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2017-07, Vol.61 (7)

2017

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model

Antimicrobial agents and chemotherapy, 2020-01, Vol.64 (2)

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model

Antimicrobial agents and chemotherapy, 2019-10, Vol.63 (10)

2019

Link zum Volltext

Verfügbarkeit prüfen

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Link zum Volltext

Verfügbarkeit prüfen

Nontoxic antimicrobials that evade drug resistance

Nature chemical biology, 2015-07, Vol.11 (7), p.481

2015

Link zum Volltext

Verfügbarkeit prüfen

In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model

Antimicrobial agents and chemotherapy, 2018-09, Vol.62 (9)

2018

Link zum Volltext

Verfügbarkeit prüfen

β-1,3 Glucan as a Test for Central Venous Catheter Biofilm Infection

The Journal of infectious diseases, 2007-06, Vol.195 (11), p.1705-1712

2007

Link zum Volltext

Verfügbarkeit prüfen

In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model

Antimicrobial agents and chemotherapy, 2015-02, Vol.59 (2), p.1258-1264

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(36)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(39)

Sprache

Englisch
(39)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(29)
Microbiology
(24)
Animals
(23)
Pharmacology & Pharmacy
(22)
Experimental Therapeutics
(15)
Mice
(15)
Microbial Sensitivity Tests
(15)
Female
(13)
Antifungal Agents - Pharmacology
(11)
Candida Albicans
(11)
Disease Models, Animal
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Biofilms
(9)
Infectious Diseases
(9)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(8)
Antifungal Agents
(8)
Humans
(8)
Pharmacodynamics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of Fks1p and Matrix Glucan in Candida albicans Biofilm Resistance to an Echinocandin, Pyrimidine, and Polyene

Isavuconazole (BAL4815) Pharmacodynamic Target Determination in an In Vivo Murine Model of Invasive Pulmonary Aspergillosis against Wild-Type and cyp51 Mutant Isolates of Aspergillus fumigatus

Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance

Posaconazole Pharmacodynamic Target Determination against Wild-Type and Cyp51 Mutant Isolates of Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

Development and Validation of an In Vivo Candida albicans Biofilm Denture Model

An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris

Host contributions to construction of three device-associated Candida albicans biofilms

Isavuconazole Pharmacodynamic Target Determination for Candida Species in an In Vivo Murine Disseminated Candidiasis Model

Impact of In Vivo Triazole and Echinocandin Combination Therapy for Invasive Pulmonary Aspergillosis: Enhanced Efficacy against Cyp51 Mutant Isolates

Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model

Eap1p, an Adhesin That Mediates Candida albicans Biofilm Formation In Vitro and In Vivo

Engineering of Streptomyces platensis MA7339 for Overproduction of Platencin and Congeners

Multilaboratory Testing of Two-Drug Combinations of Antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis

Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model

In Vivo Pharmacodynamic Evaluation of Omadacycline (PTK 0796) against Streptococcus pneumoniae in the Murine Pneumonia Model

In Vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model

In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model

In Vivo Pharmacodynamic Target Assessment of Eravacycline against Escherichia coli in a Murine Thigh Infection Model

In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model

In Vivo Pharmacodynamic Target Determination for Delafloxacin against Klebsiella pneumoniae and Pseudomonas aeruginosa in the Neutropenic Murine Pneumonia Model

APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an In Vivo Model of Invasive Pulmonary Aspergillosis

Nontoxic antimicrobials that evade drug resistance

In Vivo Pharmacodynamic Characterization of a Novel Odilorhabdin Antibiotic, NOSO-502, against Escherichia coli and Klebsiella pneumoniae in a Murine Thigh Infection Model

β-1,3 Glucan as a Test for Central Venous Catheter Biofilm Infection

In vivo pharmacokinetics and pharmacodynamics of the lantibiotic NAI-107 in a neutropenic murine thigh infection model

Suchergebnisse filtern